WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (157)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoles, E.
Right arrow Articles by Schwartz, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoles, E.
Right arrow Articles by Schwartz, M.

 Previous Article  |  Next Article 

The Journal of Neuroscience, June 1, 2001, 21(11):3740-3748

Protective Autoimmunity Is a Physiological Response to CNS Trauma

Eti Yoles1, Ehud Hauben1, Orna Palgi3, Evgenia Agranov1, Amalia Gothilf1, Avi Cohen3, Vijay Kuchroo4, Irun R. Cohen2, Howard Weiner4, and Michal Schwartz1

Departments of 1 Neurobiology and 2 Immunology, The Weizmann Institute of Science, 76100 Rehovot, Israel, 3 Proneuron Ltd., Industrial Park, Ness-Ziona, Israel, and 4 Center for Neurologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts 02115

Primary damage caused by injury to the CNS is often followed by delayed degeneration of initially spared neurons. Studies in our laboratory have shown that active or passive immunization with CNS myelin-associated self-antigens can reduce this secondary loss. Here we show, using four experimental paradigms in rodents, that CNS trauma spontaneously evokes a beneficial T cell-dependent immune response, which reduces neuronal loss. (1) Survival of retinal ganglion cells in rats was significantly higher when optic nerve injury was preceded by an unrelated CNS (spinal cord) injury. (2) Locomotor activity of rat hindlimbs (measured in an open field using a locomotor rating scale) after contusive injury of the spinal cord (T8) was significantly better (by three to four score grades) after passive transfer of myelin basic protein (MBP)-activated splenocytes derived from spinally injured rats than in untreated injured control rats or rats similarly treated with splenocytes from naive animals or with splenocytes from spinally injured rats activated ex vivo with ovalbumin or without any ex vivo activation. (3) Neuronal survival after optic nerve injury was 40% lower in adult rats devoid of mature T cells (caused by thymectomy at birth) than in normal rats. (4) Retinal ganglion cell survival after optic nerve injury was higher (119 ± 3.7%) in transgenic mice overexpressing a T cell receptor (TcR) for MBP and lower (85 ± 1.3%) in mice overexpressing a T cell receptor for the non-self antigen ovalbumin than in matched wild types. Taken together, the results imply that CNS injury evokes a T cell-dependent neuroprotective response.

Key words: protective autoimmunity; CNS injury; spinal cord injury; optic nerve injury; neuroprotection; degeneration; encephalitogenic T cells


Copyright © 2001 Society for Neuroscience  0270-6474/01/21113740-09$05.00/0


This article has been cited by other articles:


Home page
IOVSHome page
N. D. Bull, K.-A. Irvine, R. J. M. Franklin, and K. R. Martin
Transplanted Oligodendrocyte Precursor Cells Reduce Neurodegeneration in a Model of Glaucoma
Invest. Ophthalmol. Vis. Sci., September 1, 2009; 50(9): 4244 - 4253.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. K. Garg, R. Banerjee, and J. Kipnis
Neuroprotective Immunity: T Cell-Derived Glutamate Endows Astrocytes with a Neuroprotective Phenotype
J. Immunol., March 15, 2008; 180(6): 3866 - 3873.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. Rossignol, M. Schwab, M. Schwartz, and M. G. Fehlings
Spinal Cord Injury: Time to Move?
J. Neurosci., October 31, 2007; 27(44): 11782 - 11792.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. Hohlfeld, M. Kerschensteiner, and E. Meinl
Dual role of inflammation in CNS disease
Neurology, May 29, 2007; 68(22_suppl_3): S58 - S63.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Ziv, H. Avidan, S. Pluchino, G. Martino, and M. Schwartz
Synergy between immune cells and adult neural stem/progenitor cells promotes functional recovery from spinal cord injury
PNAS, August 29, 2006; 103(35): 13174 - 13179.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Monsonego, J. Imitola, S. Petrovic, V. Zota, A. Nemirovsky, R. Baron, Y. Fisher, T. Owens, and H. L. Weiner
Abeta-induced meningoencephalitis is IFN-{gamma}-dependent and is associated with T cell-dependent clearance of Abeta in a mouse model of Alzheimer's disease
PNAS, March 28, 2006; 103(13): 5048 - 5053.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Kipnis, H. Avidan, R. R. Caspi, and M. Schwartz
Dual effect of CD4+CD25+ regulatory T cells in neurodegeneration: A dialogue with microglia
PNAS, October 5, 2004; 101(suppl_2): 14663 - 14669.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
D. POZO and M. DELGADO
The many faces of VIP in neuroimmunology: a cytokine rather a neuropeptide?
FASEB J, September 1, 2004; 18(12): 1325 - 1334.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Kipnis, M. Cardon, H. Avidan, G. M. Lewitus, S. Mordechay, A. Rolls, Y. Shani, and M. Schwartz
Dopamine, through the Extracellular Signal-Regulated Kinase Pathway, Downregulates CD4+CD25+ Regulatory T-Cell Activity: Implications for Neurodegeneration
J. Neurosci., July 7, 2004; 24(27): 6133 - 6143.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Kipnis, H. Cohen, M. Cardon, Y. Ziv, and M. Schwartz
T cell deficiency leads to cognitive dysfunction: Implications for therapeutic vaccination for schizophrenia and other psychiatric conditions
PNAS, May 25, 2004; 101(21): 8180 - 8185.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. B. Jones, D. P. Ankeny, Z. Guan, V. McGaughy, L. C. Fisher, D. M. Basso, and P. G. Popovich
Passive or Active Immunization with Myelin Basic Protein Impairs Neurological Function and Exacerbates Neuropathology after Spinal Cord Injury in Rats
J. Neurosci., April 14, 2004; 24(15): 3752 - 3761.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Frenkel, Z. Huang, R. Maron, D. N. Koldzic, W. W. Hancock, M. A. Moskowitz, and H. L. Weiner
Nasal Vaccination with Myelin Oligodendrocyte Glycoprotein Reduces Stroke Size by Inducing IL-10-Producing CD4+ T Cells
J. Immunol., December 15, 2003; 171(12): 6549 - 6555.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
A. Monsonego and H. L. Weiner
Immunotherapeutic Approaches to Alzheimer's Disease
Science, October 31, 2003; 302(5646): 834 - 838.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. Hauben, A. Gothilf, A. Cohen, O. Butovsky, U. Nevo, I. Smirnov, E. Yoles, S. Akselrod, and M. Schwartz
Vaccination with Dendritic Cells Pulsed with Peptides of Myelin Basic Protein Promotes Functional Recovery from Spinal Cord Injury
J. Neurosci., September 24, 2003; 23(25): 8808 - 8819.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. Bakalash, A. Kessler, T. Mizrahi, R. Nussenblatt, and M. Schwartz
Antigenic Specificity of Immunoprotective Therapeutic Vaccination for Glaucoma
Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3374 - 3381.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. N. Angelov, S. Waibel, O. Guntinas-Lichius, M. Lenzen, W. F. Neiss, T. L. Tomov, E. Yoles, J. Kipnis, H. Schori, A. Reuter, et al.
Therapeutic vaccine for acute and chronic motor neuron diseases: Implications for amyotrophic lateral sclerosis
PNAS, April 15, 2003; 100(8): 4790 - 4795.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. Schwartz
Neurodegeneration and Neuroprotection in Glaucoma: Development of a Therapeutic Neuroprotective Vaccine: The Friedenwald Lecture
Invest. Ophthalmol. Vis. Sci., April 1, 2003; 44(4): 1407 - 1411.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Kipnis, T. Mizrahi, E. Hauben, I. Shaked, E. Shevach, and M. Schwartz
Neuroprotective autoimmunity: Naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system
PNAS, November 26, 2002; 99(24): 15620 - 15625.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Mizrahi, E. Hauben, and M. Schwartz
The Tissue-Specific Self-Pathogen Is the Protective Self-Antigen: The Case of Uveitis
J. Immunol., November 15, 2002; 169(10): 5971 - 5977.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
L. Kappos and P. Duda
The Janus face of CNS-directed autoimmune response: a therapeutic challenge
Brain, November 1, 2002; 125(11): 2379 - 2380.
[Full Text] [PDF]


Home page
NeuroscientistHome page
M. Schwartz and J. Kipnis
Multiple Sclerosis as a By-Product of the Failure to Sustain Protective Autoimmunity: A Paradigm Shift
Neuroscientist, October 1, 2002; 8(5): 405 - 413.
[Abstract] [PDF]


Home page
J. Immunol.Home page
H. Schori, F. Lantner, I. Shachar, and M. Schwartz
Severe Immunodeficiency Has Opposite Effects on Neuronal Survival in Glutamate-Susceptible and -Resistant Mice: Adverse Effect of B Cells
J. Immunol., September 15, 2002; 169(6): 2861 - 2865.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. Bakalash, J. Kipnis, E. Yoles, and M. Schwartz
Resistance of Retinal Ganglion Cells to an Increase in Intraocular Pressure Is Immune-Dependent
Invest. Ophthalmol. Vis. Sci., August 1, 2002; 43(8): 2648 - 2653.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. B. Jones, D. M. Basso, A. Sodhi, J. Z. Pan, R. P. Hart, R. C. MacCallum, S. Lee, C. C. Whitacre, and P. G. Popovich
Pathological CNS Autoimmune Disease Triggered by Traumatic Spinal Cord Injury: Implications for Autoimmune Vaccine Therapy
J. Neurosci., April 1, 2002; 22(7): 2690 - 2700.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. P. Hofstetter, E. J. Schwarz, D. Hess, J. Widenfalk, A. El Manira, D. J. Prockop, and L. Olson
Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery
PNAS, February 19, 2002; 99(4): 2199 - 2204.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Hauben, A. Ibarra, T. Mizrahi, R. Barouch, E. Agranov, and M. Schwartz
Vaccination with a Nogo-A-derived peptide after incomplete spinal-cord injury promotes recovery via a T-cell-mediated neuroprotective response: Comparison with other myelin antigens
PNAS, December 18, 2001; 98(26): 15173 - 15178.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Kipnis, E. Yoles, H. Schori, E. Hauben, I. Shaked, and M. Schwartz
Neuronal Survival after CNS Insult Is Determined by a Genetically Encoded Autoimmune Response
J. Neurosci., July 1, 2001; 21(13): 4564 - 4571.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-